Distinct molecular effects of angiotensin II and angiotensin III in rat astrocytes

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Clark, Michelle A ^a   Nguyen, Chinh ^a   Tran, Hieu ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMASTATIN A; ANGIOTENSIN II; ANGIOTENSIN III; GLUTAMATE PHOSPHONATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE HYDROLASE INHIBITOR; PHOSPHONIC ACID DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HORMONE ACTION; NERVE CELL STIMULATION; NERVE GROWTH; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 84874854674     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/782861     Document Type: Article

References (35)

1. Force T., Bonventre J. V., Growth factors and mitogen-activated protein kinases. Hypertension 1998 31 1 152 161 2-s2.0-0031600501
2. Mii S., Khalil R. A., Morgan K. G., Ware J. A., Kent K. C., Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. American Journal of Physiology 1996 270 1 H142 H150 2-s2.0-0030020402
3. Touyz R. M., Schiffrin E. L., Signal transduction in hypertension: part I. Current Opinion in Nephrology and Hypertension 1993 2 1 5 16 2-s2.0-0027341731
4. Touyz R. M., El Mabrouk M., He G., Wu X. H., Schiffrin E. L., Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circulation Research 1999 84 5 505 515 2-s2.0-0033583265 (Pubitemid 29138587)
5. Clark M., Angiotensin II activates mitogen-activated protein kinases and stimulates growth in rat medullary astrocytes. The FASEB Journal 2001 A1169
6. Clark M. A., Gonzalez N., Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation. Regulatory Peptides 2007 144 1-3 115 122 2-s2.0-35648934509 10.1016/j.regpep.2007.07.001 (Pubitemid 350030309)
7. Clark M. A., Guillaume G., Pierre-Louis H. C., Angiotensin II induces proliferation of cultured rat astrocytes through c-Jun N-terminal kinase. Brain Research Bulletin 2008 75 1 101 106 2-s2.0-37349095243 10.1016/j.brainresbull. 2007.07.028 (Pubitemid 350297646)
8. Clark M. A., Gonzalez N., Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes. Regulatory Peptides 2007 143 1-3 47 55 2-s2.0-34547683588 10.1016/j.regpep.2007.02.008 (Pubitemid 47212523)
9. Clark M. A., Nguyen C., Tran H., Angiotensin III induces c-Jun N-terminal kinase leading to proliferation of rat astrocytes. Neurochemical Research 2012 37 7 1475 1481
10. Clark M. A., Tran H., Nguyen C., Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes. Neuropeptides 2011 45 5 329 335
11. Abhold R. H., Sullivan M. J., Wright J. W., Harding J. W., Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. Journal of Pharmacology and Experimental Therapeutics 1987 242 3 957 962 2-s2.0-0023638822 (Pubitemid 17156538)
12. Zini S., Fournie-Zaluski M. C., Chauvel E., Roques B. P., Corvol P., Llorens-Cortes C., Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proceedings of the National Academy of Sciences of the United States of America 1996 93 21 11968 11973 2-s2.0-0029859206 10.1073/pnas.93.21.11968 (Pubitemid 26347232)
13. Wright J. W., Sullivan M. J., Harding J. W., Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats. Neuroscience Letters 1985 61 3 351 356 2-s2.0-0022366286 (Pubitemid 16198797)
14. Reaux A., Fournie-Zaluski M. C., David C., Zini S., Roques B. P., Corvol P., Llorens-Cortes C., Aminopeptidase A inhibitors as potential central antihypertensive agents. Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13415 13420 2-s2.0-0033539511 10.1073/pnas.96.23.13415
15. Ramírez-Expósito M. J., Martínez-Martos J. M., Mayas M. D., García M. J., Prieto I., Aréchaga G., Ramírez M., Oleate, linoleate and cholesterol differently modify aspartyl- and glutamyl-aminopeptidase activities in primary cultures of rat astrocytes. Comparative Biochemistry and Physiology C 2001 128 1 113 118 2-s2.0-0000149773
16. Stragier B., De Bundel D., Sarre S., Smolders I., Vauquelin G., Dupont A., Michotte Y., Vanderheyden P., Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Failure Reviews 2008 13 3 321 337 2-s2.0-42049103296 10.1007/s10741-007-9062-x
17. Stragier B., Sarre S., Vanderheyden P., Vauquelin G., Fournié-Zaluski M. C., Ebinger G., Michotte Y., Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. Journal of Neurochemistry 2004 90 5 1251 1257 2-s2.0-4444300891 10.1111/j.1471-4159.2004.02600.x (Pubitemid 39167358)
18. Stornetta R. L., Hawelu-Johnson C. L., Guyenet P. G., Lynch K. R., Astrocytes synthesize angiotensinogen in brain. Science 1988 242 4884 1444 1446 2-s2.0-0024241295 (Pubitemid 19008075)
19. Tallant E. A., Higson J. T., Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia 1997 19 4 333 342 (Pubitemid 27165240)
20. Freeman E. J., Chisolm G. M., Ferrario C. M., Tallant E. A., Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996 28 1 104 108 2-s2.0-0029957780 (Pubitemid 26231097)
21. Devynck M. A., Pernollet M. G., Matthews P. G., Specific receptors for des-Asp1-angiotensin II ("angiotensin III") in rat adrenals. Proceedings of the National Academy of Sciences of the United States of America 1977 74 9 4029 4032 2-s2.0-0017672743 (Pubitemid 8197768)
22. Harding J. W., Felix D., Sullivan M. J., Camara C. A., Erickson J. B., Regulja I., Abhold R. F., Wright J. W., The pivotal role at angiotensin III in the brain angiotensin system. Proceedings of the Western Pharmacology Society 1987 30 11 15 2-s2.0-0023084363
23. Reaux A., Fournie-Zaluski M. C., Llorens-Cortes C., Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends in Endocrinology and Metabolism 2001 12 4 157 162 2-s2.0-0035347330 (Pubitemid 33713556)
24. Wright J. W., Tamura-Myers E., Wilson W. L., Roques B. P., Llorens-Cortes C., Speth R. C., Harding J. W., Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. American Journal of Physiology 2003 284 3 R725 R733 2-s2.0-0037343289 (Pubitemid 36342805)
25. Harding J. W., Felix D., The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain. Brain Research 1987 424 2 299 304 2-s2.0-0023589150 (Pubitemid 18047674)
26. Speth R. C., Karamyan V. T., The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Failure Reviews 2008 13 3 299 309 2-s2.0-42049097442 10.1007/s10741-007-9078-2
27. Kokje R. J., Wilson W. L., Brown T. E., Karamyan V. T., Wright J. W., Speth R. C., Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis. Hypertension 2007 49 6 1328 1335 2-s2.0-34249336753 10.1161/HYPERTENSIONAHA.107.087130 (Pubitemid 46809376)
28. Karamyan V. T., Gadepalli R., Rimoldi J. M., Speth R. C., Brain AT1 angiotensin receptor subtype binding: importance of peptidase inhibition for identification of angiotensin II as its endogenous ligand. Journal of Pharmacology and Experimental Therapeutics 2009 331 1 170 177 2-s2.0-70349314527 10.1124/jpet.109.157461
29. Wright J. W., Mizutani S., Harding J. W., Focus on brain angiotensin III and aminopeptidase A in the control of hypertension. International Journal of Hypertension 2012 2012 12 124758 10.1155/2012/124758
30. Blair-West J. R., Carey K. D., Denton D. A., Madden L. J., Weisinger R. S., Shade R. E., Possible contribution of brain angiotensin III to ingestive behaviors in baboons. American Journal of Physiology 2001 281 5 R1633 R1636 2-s2.0-0035194740
31. Tseng C. J., Chou L. L., Ger L. P., Tung C. S., Cardiovascular effects of angiotensin III in brainstem nuclei of normotensive and hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 1994 268 2 558 564 2-s2.0-0028204353
32. Wilson W. L., Roques B. P., Llorens-Cortes C., Speth R. C., Harding J. W., Wright J. W., Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Research 2005 1060 1-2 108 117 2-s2.0-26944437984 10.1016/j.brainres.2005.08.032 (Pubitemid 41483595)
33. Chen C. Y., Huang W. C., Pressor and renal effects of intracerebroventricularly administered angiotensins II and III in rats. Kidney and Blood Pressure Research 2000 23 2 95 105 2-s2.0-0034070843
34. Blume A., Undeutsch C., Zhao Y., Kaschina E., Culman J., Unger T., ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. American Journal of Physiology 2005 289 3 R845 R850 2-s2.0-23944451788 10.1152/ajpregu.00672.2004 (Pubitemid 41208451)
35. Gammelgaard I., Wamberg S., Bie P., Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin- aldosterone-system. Acta Physiologica 2006 188 2 129 138 2-s2.0-33748362188 10.1111/j.1748-1716.2006.01595.x (Pubitemid 44337810)